US Patent 8309532 Therapeutic uses of inhibitors of RTP801
Patent 8309532 was granted and assigned to Quark Pharmaceuticals Inc on November, 2012 by the United States Patent and Trademark Office.
Is a
Date Filed
June 17, 2010
Date of Patent
November 13, 2012
Patent Application Number
12803118
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8309532 Therapeutic uses of inhibitors of RTP801
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
